Editorial: Etiopathogenesis of Systemic Sclerosis: An Update

Editorial: Etiopathogenesis of Systemic Sclerosis: An Update

Bibliographic Details
Main Authors:	Giuseppina Stifano, Raffaele De Palma
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-03-01
Series:	Frontiers in Immunology
Subjects:	systemic sclerosis (scleroderma) autoimmunity vascular injury fibrosis immune response
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.663381/full

Similar Items

Potential Biomarkers in Systemic Sclerosis: A Literature Review and Update
by: Akira Utsunomiya, et al.
Published: (2020-10-01)

Serum concentrations of IL-17A, IL-17B, IL-17E and IL-17F in patients with systemic sclerosis
by: Ewa Robak, et al.
Published: (2019-04-01)

Case Report: Systemic Sclerosis After Covid-19 Infection
by: Serena Fineschi, et al.
Published: (2021-06-01)

Epidemiology, Mortality and Healthcare Resource Utilization Associated With Systemic Sclerosis-Associated Interstitial Lung Disease in France
by: Vincent Cottin, et al.
Published: (2021-08-01)

Autoantibodies in systemic sclerosis: Unanswered questions
by: CRISTIANE eKAYSER, et al.
Published: (2015-04-01)

Biomarkers for Pulmonary Vascular Remodeling in Systemic Sclerosis: A Pathophysiological Approach
by: Balazs Odler, et al.
Published: (2018-06-01)

Autoantibody status in systemic sclerosis patients defines both cancer risk and survival with ANA negativity in cases with concomitant cancer having a worse survival
by: Abdulla Watad, et al.
Published: (2019-06-01)

The Roles of IL-1 Family Cytokines in the Pathogenesis of Systemic Sclerosis
by: Dan Xu, et al.
Published: (2019-09-01)

Calcified lymph nodes and systemic sclerosis
by: Fotini Angelopoulou, et al.
Published: (2018-01-01)

Localized scleroderma: A rare clinical entity
by: Ranjana Garg, et al.
Published: (2014-01-01)

Intriguing Relationships Between Cancer and Systemic Sclerosis: Role of the Immune System and Other Contributors
by: Alexandre Thibault Jacques Maria, et al.
Published: (2019-01-01)

Treatment of Systemic Sclerosis Associated Interstitial Lung Disease
by: Iris Yan Ki Tang, et al.
Published: (2020-12-01)

Systemic Sclerosis Sine Scleroderma Manifested with Gastrointestinal Bleeding, Antiphospholipid Syndrome and Positive Anti-RNA Polymerase III Antibody: Case Report and Literature Review
by: Alghamdi M, et al.
Published: (2020-08-01)

Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline
by: M. Colaci, et al.
Published: (2016-05-01)

The “myth” of loss of angiogenesis in systemic sclerosis: a pivotal early pathogenetic process or just a late unavoidable event?
by: Marco Matucci-Cerinic, et al.
Published: (2017-07-01)

Fibrosis Development in HOCl-Induced Systemic Sclerosis: A Multistage Process Hampered by Mesenchymal Stem Cells
by: Alexandre T. J. Maria, et al.
Published: (2018-11-01)

Psychosocial effects of systemic sclerosis: A case report
by: Esra Oksel
Published: (2020-07-01)

Systemic sclerosis induced by interferon-alfa treatment of melanoma.
by: Joana Leite Silva, et al.
Published: (2017-07-01)

Type 2A von Willebrand disease and systemic sclerosis: Vonicog alfa reduced gastrointestinal bleeding
by: Peter Korsten, et al.
Published: (2020-10-01)

Renal Involvement in Systemic Sclerosis: An Update
by: Magdalena Chrabaszcz, et al.
Published: (2020-06-01)

Targeted Therapy in Systemic Sclerosis
by: Murray Baron
Published: (2016-10-01)

Fingerprint abnormalities in systemic sclerosis: Results of a single center pilot study
by: Kodishala Chanakya, et al.
Published: (2018-01-01)

Capillaroscopy 2016: new perspectives in systemic sclerosis
by: Carmen Pizzorni, et al.
Published: (2016-01-01)

Formyl Peptide Receptor 2 Activation Ameliorates Dermal Fibrosis and Inflammation in Bleomycin-Induced Scleroderma
by: Gyu Tae Park, et al.
Published: (2019-09-01)

Echinochrome A Treatment Alleviates Fibrosis and Inflammation in Bleomycin-Induced Scleroderma
by: Gyu-Tae Park, et al.
Published: (2021-04-01)

Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications
by: Mirko Manetti, et al.
Published: (2019-08-01)

Systemic sclerosis: Current concepts in pathogenesis and therapeutic aspects of dermatological manifestations
by: Vishalakshi Viswanath, et al.
Published: (2013-01-01)

Association Between DNA Damage Response, Fibrosis and Type I Interferon Signature in Systemic Sclerosis
by: Nikolaos I. Vlachogiannis, et al.
Published: (2020-10-01)

Editorial: Interstitial Lung Disease in the Context of Systemic Disease: Pathophysiology, Treatment and Outcomes
by: Peter Korsten, et al.
Published: (2021-01-01)

CURRENT VIEWS ON THE HETEROGENEITY OF RENAL INVOLVEMENTS IN PATIENTS WITH SYSTEMIC SCLEROSIS
by: A. V. Gordeev, et al.
Published: (2015-09-01)

Diffuse Systemic Sclerosis with Left Ventricular Diastolic Dysfunction: A Case Report
by: Asmita Neupane, et al.
Published: (2019-12-01)

Genetic Interactions Affect Lung Function in Patients with Systemic Sclerosis
by: Anna Tyler, et al.
Published: (2020-01-01)

Circulating adipokines and organ involvement in patients with systemic sclerosis
by: Anna Olewicz-Gawlik, et al.
Published: (2015-04-01)

Elevated Circulatory Levels of Microparticles Are Associated to Lung Fibrosis and Vasculopathy During Systemic Sclerosis
by: Damien Leleu, et al.
Published: (2020-10-01)

A review of hematopoietic stem cell transplantation for autoimmune diseases: multiple sclerosis, systemic sclerosis and Crohn's disease. Position paper of the Brazilian Society of Bone Marrow Transplantation
by: Maria Carolina Oliveira, et al.
Published: (2021-01-01)

Pericostal tuberculosis in a patient with systemic sclerosis:The relationship of two rare diseases
by: Naoho Takizawa, et al.
Published: (2021-09-01)

Multiparametric autoantibody profiling of patients with systemic sclerosis in Greece
by: Christos Liaskos, et al.
Published: (2018-01-01)

Incidence and prevalence of systemic sclerosis in Campo Grande, State of Mato Grosso do Sul, Brazil
by: Alex Magno Coelho Horimoto, et al.

A 3-Year Observational Study of Patients with Progressive Systemic Sclerosis Treated with an Intensified B Lymphocyte Depletion Protocol: Clinical and Immunological Response
by: Daniela Rossi, et al.
Published: (2021-01-01)

Current perspectives on the immunopathogenesis of systemic sclerosis
by: Fuschiotti P
Published: (2016-04-01)

Cannot write session to /tmp/vufind_sessions/sess_nu6f287fi7fki788o91db07jg7